Regulatory Analysis
Navigate complex regulatory environments with complete regulatory strategy advisory from approval pathway assessment to post-market compliance.
Our Regulatory Analysis Services portfolio exists to assist healthcare organizations and life sciences organizations in their efforts to navigate complex regulatory environments that continuously evolve. Our team offers complete regulatory strategy advisory services that support the approval process for pharmaceuticals and biotechnology products, medical devices, diagnostics and healthcare service organizations.
Key Highlights
Our expertise includes monitoring regulatory intelligence, reviewing clinical and technical documents, aligning quality systems, assessing labeling and claims, and developing post-market compliance strategies.
Our company helps clients achieve faster approval times, decreased compliance risks, and sustained market access in multiple international markets.
We provide services that combine regulatory needs with business goals and development plans to ensure comprehensive compliance and market readiness.
Our approach ensures alignment with local and global regulatory standards through gap analysis and strategic planning.
What's Included
- Regulatory pathway assessment and approval strategy development
- Gap analysis against local and global regulatory standards
- Regulatory intelligence monitoring and policy tracking
- Submission strategy planning (IND, NDA, ANDA, 510(k), CE, etc.)
- Technical documentation and dossier review
- Clinical and non-clinical data compliance evaluation
- Quality Management System (QMS) alignment and advisory
- GMP, GLP, and GCP compliance assessment
- Labeling, claims, and promotional material review
- Risk assessment and mitigation planning
- Audit readiness and inspection support